Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,180) with videos related to
Page
of 118
Sort By:
Brain Communications
|
December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
Charis Wong, Maria Stavrou, Elizabeth Elliott, et al.
Acta Neuropathologica
|
June 24, 2020
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
Simon Licht-Mayer, Graham R Campbell, Marco Canizares, et al.
Brain Communications
|
August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
Ross W Paterson, Laura A Benjamin, Puja R Mehta, et al.
JAMA
|
September 3, 2013
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial
Philippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.
Nature Neuroscience
|
November 1, 2025
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD
Brian J Joseph, Kelly A Marshall, Peter Harley, et al.
Circulation
|
March 31, 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure
Barry A Borlaug, John Blair, Martin W Bergmann, et al.
Indian Journal of Ophthalmology
|
June 27, 2020
A new normal with cataract surgery during COVID-19 pandemic
Jagadesh C Reddy, Pravin K Vaddavalli, Namrata Sharma, et al.
BMJ Open
|
February 1, 2023
Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus
Charis Wong, Jenna M Gregory, Jing Liao, et al.
The New England Journal of Medicine
|
February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangioma
Christine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
Nature Communications
|
November 13, 2022
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
Sarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, et al.
Page
of 118
Search research articles
Search
Showing results (1151-1160 of 1,180) with videos related to
Sort By:
Page
of 118
Brain Communications
|
December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
Charis Wong, Maria Stavrou, Elizabeth Elliott, et al.
Acta Neuropathologica
|
June 24, 2020
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
Simon Licht-Mayer, Graham R Campbell, Marco Canizares, et al.
Brain Communications
|
August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
Ross W Paterson, Laura A Benjamin, Puja R Mehta, et al.
JAMA
|
September 3, 2013
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial
Philippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.
Nature Neuroscience
|
November 1, 2025
TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD
Brian J Joseph, Kelly A Marshall, Peter Harley, et al.
Circulation
|
March 31, 2022
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure
Barry A Borlaug, John Blair, Martin W Bergmann, et al.
Indian Journal of Ophthalmology
|
June 27, 2020
A new normal with cataract surgery during COVID-19 pandemic
Jagadesh C Reddy, Pravin K Vaddavalli, Namrata Sharma, et al.
BMJ Open
|
February 1, 2023
Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus
Charis Wong, Jenna M Gregory, Jing Liao, et al.
The New England Journal of Medicine
|
February 19, 2015
A randomized, controlled trial of oral propranolol in infantile hemangioma
Christine Léauté-Labrèze, Peter Hoeger, Juliette Mazereeuw-Hautier, et al.
Nature Communications
|
November 13, 2022
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration
Sarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, et al.
Page
of 118